← Back to Search

Treatment for Prostate Cancer

N/A
Waitlist Available
Led By Silvia Formenti, M.D.
Research Sponsored by Weill Medical College of Cornell University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4 years
Awards & highlights

Summary

Exposure to radiation can impact immune cells that are present in the blood, such as lymphocytes. It is hypothesized that larger radiation fields and/or longer courses of radiation, result in greater decrease in immune cells. To test this hypothesis, investigators will take blood samples from subjects undergoing two different standard of care radiation regimens for prostate cancer, and subjects undergoing two different standard of care regimens for breast cancer.

Eligible Conditions
  • Prostate Cancer
  • Breast Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 4 years for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
distribution and frequency of peripheral immune mediators before, during and after radiotherapy will be assessed from blood samples that are collected at various time points
prospectively collecting blood specimens to assess peripheral immune mediatiors in 4 distinct clinical settings
Secondary study objectives
microbiome changes associated with different radiation treatments through collection of stool microbiome samples at different time points

Find a Location

Who is running the clinical trial?

Varian Medical SystemsIndustry Sponsor
61 Previous Clinical Trials
3,578 Total Patients Enrolled
4 Trials studying Prostate Cancer
354 Patients Enrolled for Prostate Cancer
Weill Medical College of Cornell UniversityLead Sponsor
1,077 Previous Clinical Trials
1,320,601 Total Patients Enrolled
49 Trials studying Prostate Cancer
34,603 Patients Enrolled for Prostate Cancer
Silvia Formenti, M.D.Principal InvestigatorWeill Cornell Medicine - New York Presbyterian Hospital
13 Previous Clinical Trials
1,267 Total Patients Enrolled
2 Trials studying Prostate Cancer
51 Patients Enrolled for Prostate Cancer
~9 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top